Independent by design

About

Long Waypoint 57 is an independent resource on ibogaine law, research, and safety. Civic Marigold helps people understand the legal reality, research status, and safety concerns surrounding ibogaine in the United States.

For people affected by substance use, families, advocates, and professionals seeking clear information without treatment claims or promotional framing.

Hands holding printed pages while reviewing independent ibogaine information

Make the record easier to read.

Long Waypoint 57 exists because important decisions are often made around scattered, unequal, or overstated information. It offers an independent reference about ibogaine clinics in the United States while keeping the focus on what can be checked, what remains uncertain, and what should not be represented as settled.

Its starting point is the legal-and-safety overview collected across the site: not a treatment pathway, and not a substitute for professional judgment. The work is organized so a reader can move from a broad question to the relevant page without being pushed toward a provider, product, or outcome.

That approach follows a basic public-information principle: primary materials and accountable institutions deserve more weight than promotional claims. For example, the FDA’s outline of drug development and approval provides a useful reference point for separating formal research pathways from claims that merely sound clinical.

Our editorial approach

Check the source. Name the limit.

We organize material around public records, research literature, official sources, and plainly identified uncertainty. When a source does not support a strong conclusion, the language should not pretend otherwise. The resource’s wayfinding materials and plain-language guides are meant to help readers identify the kind of question they are asking before they act on it.

Research references are treated as evidence with boundaries, not as endorsements. Readers can use PubMed’s biomedical literature database to see how published work is indexed and to distinguish a citation from a guarantee.

Printed materials arranged for careful review of sources and research context

What guides the work

No shortcuts on clarity

Legal clarity State what an official source says, distinguish it from interpretation, and leave room for changing rules.
Evidence before claims Put registries, published literature, and primary documentation ahead of promotional language.
Safety awareness Do not minimize uncertainty, contraindications, or the difference between information and care.
Plain language Explain the terms that shape a decision without asking readers to accept more than the record supports.
Independence Keep this resource separate from clinic, provider, and treatment-center claims.

Who this is for

A place to orient, not to be sold to.

This resource is for people affected by substance use, families, advocates, and professionals who need a calmer starting point. It groups related questions so readers can compare context: a discussion of Texas policy developments around ibogaine belongs beside broader legal context, while ibogaine and ayahuasca comparisons should not be treated as interchangeable evidence.

Practical questions also require careful framing. Pages addressing Arizona treatment searches, an ibogaine trip report, and retreat cost questions are organized as information pathways, not referrals or recommendations.

The same distinction applies when readers encounter claims about ibogaine for opioid addiction, lists of ibogaine detox centers, an ibogaine clinic in Tijuana, general ibogaine cost estimates, or treatment centers in Europe. Those subjects may matter to a reader, but their presence here does not establish legality, safety, quality, or suitability.

“The point is not to make a hard question feel easy. It is to make the available record easier to inspect.”